Literature DB >> 8044845

Crystal structure of the cysteine protease interleukin-1 beta-converting enzyme: a (p20/p10)2 homodimer.

N P Walker1, R V Talanian, K D Brady, L C Dang, N J Bump, C R Ferenz, S Franklin, T Ghayur, M C Hackett, L D Hammill.   

Abstract

Interleukin-1 beta-converting enzyme (ICE) proteolytically cleaves pro-IL-1 beta to its mature, active form. The crystal structure at 2.5 A resolution of a recombinant human ICE-tetrapeptide chloromethylketone complex reveals that the holoenzyme is a homodimer of catalytic domains, each of which contains a p20 and a p10 subunit. The spatial separation of the C-terminus of p20 and the N-terminus of p10 in each domain suggests two alternative pathways of assembly and activation in vivo. ICE is homologous to the C. elegans cell death gene product, CED-3, and these may represent a novel class of cytoplasmic cysteine proteases that are important in programmed cell death (apoptosis). Conservation among members of the ICE/CED-3 family of the amino acids that form the active site region of ICE supports the hypothesis that they share functional similarities.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8044845     DOI: 10.1016/0092-8674(94)90303-4

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  85 in total

Review 1.  Caspase inhibitors in prevention of apoptosis.

Authors:  T Rudel
Journal:  Herz       Date:  1999-05       Impact factor: 1.443

2.  The structure of procaspase 6 is similar to that of active mature caspase 6.

Authors:  Byoung Heon Kang; Eunsil Ko; Oh-Keun Kwon; Kwan Yong Choi
Journal:  Biochem J       Date:  2002-06-15       Impact factor: 3.857

Review 3.  The protein structures that shape caspase activity, specificity, activation and inhibition.

Authors:  Pablo Fuentes-Prior; Guy S Salvesen
Journal:  Biochem J       Date:  2004-12-01       Impact factor: 3.857

Review 4.  Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells.

Authors:  Susan L Fink; Brad T Cookson
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

Review 5.  Caspases: pharmacological manipulation of cell death.

Authors:  Inna N Lavrik; Alexander Golks; Peter H Krammer
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

6.  Anthrax lethal toxin-induced inflammasome formation and caspase-1 activation are late events dependent on ion fluxes and the proteasome.

Authors:  Katherine E Wickliffe; Stephen H Leppla; Mahtab Moayeri
Journal:  Cell Microbiol       Date:  2007-09-10       Impact factor: 3.715

Review 7.  Proteases in cardiometabolic diseases: Pathophysiology, molecular mechanisms and clinical applications.

Authors:  Yinan Hua; Sreejayan Nair
Journal:  Biochim Biophys Acta       Date:  2014-05-09

8.  Vitamin D3 induces caspase-14 expression in psoriatic lesions and enhances caspase-14 processing in organotypic skin cultures.

Authors:  Saskia Lippens; Mark Kockx; Geertrui Denecker; Michiel Knaapen; An Verheyen; Ruben Christiaen; Erwin Tschachler; Peter Vandenabeele; Wim Declercq
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

9.  A theoretical study of the active sites of papain and S195C rat trypsin: implications for the low reactivity of mutant serine proteinases.

Authors:  A J Beveridge
Journal:  Protein Sci       Date:  1996-07       Impact factor: 6.725

10.  Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors.

Authors:  A G Uren; M Pakusch; C J Hawkins; K L Puls; D L Vaux
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.